Physician profile
Jason Atwell
NPI 1477010130
$339.29
in general payments reported to CMS, 2019-2025
13 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Gerontology (Registered Nurse) provider received nationally (typical 2025 total: $85.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.13 · 2022: $45.69 · 2023: $43.87 · 2024: $14.85 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $85.39 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.94 | 2022-2025 | Relistor |
| Tonix Medicines, INC. | $38.62 | 2025 | Tonmya |
| Lundbeck LLC | $19.38 | 2025 | Vyepti |
| Vertex Pharmaceuticals Incorporated | $17.73 | 2025 | |
| Medtronic, INC. | $16.30 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.84 | 2023 | Gvoke Hypopen |
| Axsome Therapeutics, INC. | $15.68 | 2025 | Auvelity |
| Azurity Pharmaceuticals, INC. | $14.85 | 2024 | Horizant |
| Novo Nordisk INC | $14.61 | 2023 | Wegovy |
| Kowa Pharmaceuticals America, INC. | $14.40 | 2022 | |
| Lilly USA, LLC | $13.42 | 2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Atwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.